Yahoo Αναζήτηση Διαδυκτίου

Αποτελέσματα Αναζήτησης

  1. This is the American ICD-10-CM version of D57.2 - other international versions of ICD-10 D57.2 may differ. One of the sickle cell disorders characterized by the presence of both hemoglobin s and hemoglobin c. It is similar to, but less severe than sickle cell anemia.

    • D57.40

      D57.40 is a billable/specific ICD-10-CM code that can be...

  2. Haemoglobin SC disease is a sickling disorder which results from the co-inheritance of two abnormal ß globin genes, haemoglobin S and haemoglobin C (ß s ß c). It is characterised by the presence of SC poikilocytes, abnormally contracted cells which resemble sickle cells but which have straight edges or are branched.

  3. 4 Οκτ 2022 · Sickle cell disease (SCD) is an inherited group of disorders characterized by the presence of hemoglobin S (Hb S), either from homozygosity for the sickle mutation (Hb SS) or compound heterozygosity with another beta globin variant (eg, sickle-beta thalassemia, Hb SC disease).

  4. Hemoglobin S-C disease is suspected in patients whose clinical features suggest sickle cell disease or whose red blood cells demonstrate sickling. Stained blood smears show target cells, spherocytes, and rarely sickle cells or oat-shaped cells.

  5. Conclusions Our data suggest that hemoglobin SC disease should not be considered as a mild form of sickle cell anemia but as a separate disease with a special emphasis on viscosity-associated otological and ophthalmological disorders, and with a low prevalence of vasculopathy (strokes, pulmonary hypertension, ulcers and nephropathy). Phlebotomy ...

  6. Sickle cell-hemoglobin C disease syndrome. A rare, genetic hemoglobinopathy characterized by anemia, reticulocytosis and erythrocyte abnormalities including target cells, irreversibly sickled cells and crystal-containing cells.

  7. D57.2 is a non-specific and non-billable diagnosis code code, consider using a code with a higher level of specificity for a diagnosis of sickle-cell/hb-c disease. The code is not specific and is NOT valid for the year 2025 for the submission of HIPAA-covered transactions.